Incyte licensed Enable's enFuse technology for its pipeline asset INCA033989, indicating investment in novel drug delivery automation. This creates needs for technology integration, quality control systems, and supply chain management for the new device.
Filing excerpt
In October 2025, we announced an agreement with Enable Injections, Inc. (“Enable”) to develop for use with specific assets in our portfolio, including INCA033989, Enable’s enFuse on-body delivery system.
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
Vendors named
sec-10kautomationInvestmentGet every 10-K signal for Incyte and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Incyte this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/d743c41d-a2ad-4977-80e4-0a15ad7b8ce9 returns this record as JSON. POST /v1/companies/enrich returns every signal for incyte.com.
{
"signal_id": "d743c41d-a2ad-4977-80e4-0a15ad7b8ce9",
"signal_type": "sec-10k",
"signal_subtype": "automationInvestment",
"detected_at": "2026-02-17T06:34:03.067+00:00",
"company": {
"name": "Incyte",
"domain": "incyte.com"
},
"data": {
"detail": "Incyte licensed Enable's enFuse technology for its pipeline asset INCA033989, indicating investment in novel drug delivery automation. This creates needs for technology integration, quality control systems, and supply chain management for the new device.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Partnered with Enable Injections in Oct 2025 for enFuse on-body drug delivery system.",
"excerpts": "In October 2025, we announced an agreement with Enable Injections, Inc. (“Enable”) to develop for use with specific assets in our portfolio, including INCA033989, Enable’s enFuse on-body delivery system.",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/879169/000087916926000010/incy-20251231.htm",
"filing_date": "2026-02-10",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Automation vendor opportunity",
"signal_category": "technology",
"vendors_mentioned": [
"Enable Injections, Inc."
]
}
}
curl https://signals.autobound.ai/v1/signals/d743c41d-a2ad-4977-80e4-0a15ad7b8ce9 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"incyte.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.